Showing results (511-520 of 2,481) with videos related to

Sort By:
Pageof 249
Pediatric Hematology and Oncology|January 1, 1986
Influence of food intake on bioavailability of oral 6-mercaptopurine in children with acute lymphoblastic leukemiaR Riccardi, F M Balis, P Ferrara, et al.
Pediatric Hematology and Oncology|January 1, 1986
Effects of methotrexate on rabbit testes. Part 1: Morphological changesM Koehler, R Waldherr, R Ludwig, et al.
Pediatric Hematology and Oncology|January 1, 1986
Long-term results in childhood rhabdomyosarcoma: a retrospective study in ItalyM Carli, B De Bernardi, M Castello, et al.
Pediatric Hematology and Oncology|July 31, 2019
ZRSR2 mutation in a child with refractory macrocytic anemia and Down SyndromeMeghna Srinath, Emily Coberly, Kimberly Ebersol, et al.
Pediatric Hematology and Oncology|September 21, 2019
Potassium supplementation mitigates corticosteroid-induced neuropsychiatric effects in pediatric oncology patientsHolly Pariury, John Willhoite, Jennifer Michlitsch, et al.
Pediatric Hematology and Oncology|July 25, 2019
The clinical characteristics of Congolese children and adolescents suffering from sickle-cell anemia are marked by the high frequencies of epistaxis compared to Western seriesAimé L Kazadi, René M Ngiyulu, Jean L Gini-Ehungu, et al.
Pediatric Hematology and Oncology|January 1, 1987
42-hour methotrexate infusions as relapse therapy for childhood malignancies: toxicity and efficacy of 109 infusionsU Bode, M Erps, D Schiffer
Pediatric Hematology and Oncology|January 1, 1987
Definition of response and remission in children over one year of age with advanced neuroblastoma: proposition for a scoring systemT Philip, L Helson, J L Bernard, et al.
Pediatric Hematology and Oncology|January 1, 1987
Action of intermediate doses of methotrexate on dihydrofolate reductase in malignant diseasesF Tzortzatou-Stathopoulou, H Zavitsa-Pateli, G Mousatos, et al.
Pediatric Hematology and Oncology|January 1, 1987
Single-agent ifosfamide in patients with recurrent neuroblastoma (ENSG study 2). European Neuroblastoma Study GroupJ de Kraker, J Pritchard, O Hartmann, et al.
Pageof 249